MedPath

Vitamin D3

Generic Name
Vitamin D3
Brand Names
Adrovance, Animi-3 With Vitamin D, Citranatal B-calm Kit, Citranatal Harmony, Fosamax Plus D, Fosavance, Infuvite, Infuvite Pediatric, Mvc-fluoride, Natafort, Pregvit, Vidextra
Drug Type
Small Molecule
Chemical Formula
C27H44O
CAS Number
67-97-0
Unique Ingredient Identifier
1C6V77QF41
Background

Vitamin D, in general, is a secosteroid generated in the skin when 7-dehydrocholesterol located there interacts with ultraviolet irradiation - like that commonly found in sunlight . Both the endogenous form of vitamin D (that results from 7-dehydrocholesterol transformation), vitamin D3 (cholecalciferol), and the plant-derived form, vitamin D2 (ergocalciferol), are considered the main forms of vitamin d and are found in various types of food for daily intake . Structurally, ergocalciferol differs from cholecalciferol in that it possesses a double bond between C22 and C23 and has an additional methyl group at C24 . Finally, ergocalciferol is pharmacologically less potent than cholecalciferol, which makes vitamin D3 the preferred agent for medical use .

Appropriate levels of vitamin D must be upheld in the body in order to maintain calcium and phosphorus levels in a healthy physiologic range to sustain a variety of metabolic functions, transcription regulation, and bone metabolism . However, studies are also ongoing to determine whether or not cholecalciferol may also play certain roles in cancer, autoimmune disorders, cardiovascular disease, and other medical conditions that may be associated with vitamin D deficiency .

Indication

Cholecalciferol use is indicated for the treatment of specific medical conditions like refractory rickets (or vitamin D resistant rickets), hypoparathyroidism, and familial hypophosphatemia .

Concurrently, as one of the most commonly utilized forms of vitamin D, cholecalciferol is also very frequently used as a supplement in individuals to maintain sufficient vitamin d levels in the body or to treat vitamin D deficiency, as well as various medical conditions that can be associated directly or indirectly with vitamin d insufficiency like osteoporosis and chronic kidney disease, among others .

Associated Conditions
Bone Fractures, Calcium and Vitamin D Deficiencies, Deficiency of Vitamin D3, Deficiency, Vitamin A, Deficiency, Vitamin D, Hip Fracture, Hypoparathyroidism, Hypophosphatemia, Familial, Menopause, Osteomalacia, Osteoporosis, Postmenopausal Osteoporosis, Vertebral Fractures, Vitamin D Resistant Rickets, Vitamin Deficiency, Severe Bone Resorption, Spine fracture
Associated Therapies
Calcium supplementation, Nutritional supplementation, Vitamin D Supplementation, Vitamin supplementation

Study to Evaluate Efficacy of Odanacatib (MK-0822) on Bone Mineral Density (BMD) and Bone Micro-architecture and Overall Safety in Postmenopausal Women (MK-0822-031)

Phase 3
Completed
Conditions
Osteoporosis
Interventions
First Posted Date
2008-08-07
Last Posted Date
2018-08-27
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
214
Registration Number
NCT00729183

Vitamin D for Painful Nocturnal Leg Cramps

Not Applicable
Terminated
Conditions
Leg Cramps, Nocturnal
Interventions
Drug: placebo
Drug: vitamin d
First Posted Date
2008-07-15
Last Posted Date
2019-09-17
Lead Sponsor
University of Wisconsin, Madison
Target Recruit Count
29
Registration Number
NCT00715429
Locations
🇺🇸

University of Wisconsin, Madison, Wisconsin, United States

Vitamin D3 in Systemic Lupus Erythematosus

Phase 2
Completed
Conditions
SLE
Lupus
Systemic Lupus Erythematosus
Interventions
Drug: Vitamin D3 placebo
Drug: Vitamin D3
First Posted Date
2008-07-03
Last Posted Date
2017-04-26
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
57
Registration Number
NCT00710021
Locations
🇺🇸

University of Rochester, Rochester, New York, United States

🇺🇸

University of Alabama, Birmingham, Alabama, United States

🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

and more 5 locations

Vitamin D for the Prevention of Diabetes Type 2

Phase 2
Completed
Conditions
Impaired Glucose Tolerance
Interventions
First Posted Date
2008-05-28
Last Posted Date
2015-09-22
Lead Sponsor
University of Tromso
Target Recruit Count
511
Registration Number
NCT00685594
Locations
🇳🇴

University of Tromso, Tromso, Norway

Cholecalciferol Supplementation, Muscle Strength

Phase 1
Completed
Conditions
Vitamin D Deficiency
Interventions
First Posted Date
2008-05-22
Last Posted Date
2011-06-15
Lead Sponsor
Indian Council of Medical Research
Target Recruit Count
40
Registration Number
NCT00682214

Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease

Not Applicable
Completed
Conditions
End-Stage Renal Disease
Interventions
First Posted Date
2008-05-14
Last Posted Date
2014-04-29
Lead Sponsor
University of Kansas
Target Recruit Count
7
Registration Number
NCT00677534

L-arginine and Vitamin D Adjunctive Therapy in Pulmonary Tuberculosis (TB)

Phase 3
Completed
Conditions
Smear Positive Pulmonary Tuberculosis
Interventions
First Posted Date
2008-05-14
Last Posted Date
2012-01-18
Lead Sponsor
Menzies School of Health Research
Target Recruit Count
200
Registration Number
NCT00677339
Locations
🇮🇩

Timika Tuberculosis Clinic and Community Hospital, Timika, Papua Province, Indonesia

Effect of Vitamin D Treatment in Primary Hyperparathyroidism

Phase 2
Completed
Conditions
Vitamin D Deficiency
Primary Hyperparathyroidism
Hypercalcemia
Interventions
First Posted Date
2008-05-07
Last Posted Date
2013-11-18
Lead Sponsor
University of Aarhus
Target Recruit Count
46
Registration Number
NCT00674154
Locations
🇩🇰

Osteoporoseklinikken, Aarhus University Hospital, THG, Aarhus C, Denmark

Development of Vitamin D as a Therapy for Breast Cancer - Phase 2

Phase 2
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2008-04-10
Last Posted Date
2017-12-02
Lead Sponsor
Stanford University
Target Recruit Count
63
Registration Number
NCT00656019
Locations
🇺🇸

Stanford University School of Medicine, Stanford, California, United States

High-Dose Vitamin D Deficiency in Burn Injury

Phase 3
Withdrawn
Conditions
Burn
Interventions
First Posted Date
2008-01-11
Last Posted Date
2012-11-15
Lead Sponsor
The University of Texas Medical Branch, Galveston
Registration Number
NCT00591604
© Copyright 2025. All Rights Reserved by MedPath